Mr. Joyce discusses Sigyn Therapeutics vision for addressing life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome stating, Cytokine Storm Syndrome is a dis-regulated immune response that results in the overproduction of inflammatory cytokines that can induce organ failure and cause death. It can be triggered by a wide range of infectious conditions and is a leading cause of death related to severe COVID-19 infections. It also underlies sepsis, which is the number one cause of in-hospital deaths worldwide and an annual market opportunity that exceeds $20 billion. Mr Joyce added that: Cytokine Storm Syndrome can also be triggered by non-infectious disease conditions such as an adverse response to drug therapies including emerging cancer immunotherapies.
AI Eye Podcast #504: GBT Tokenize Developing Health Analysis Methods Based on Kirlian Electrophotography Research and NICE (NasdaqGS: $NICE) Introduces New AI-Based RPA Capabilities
Point Roberts, WA and Vancouver, BC - January 6, 2021 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today s edition of
The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence - featuring technology company GBT Technologies Inc. (OTCPINK:GTCH)..
Listen to today s podcast:
SHARE PODCAST:
Stocks discussed: (OTCPINK:GTCH) (NasdaqGS:NICE)
GBT Tokenize Corp, the joint venture of GBT Technologies Inc. (OTC PINK:GTCH), is developing new methods for health analysis based on its Kirlian Electrophotography research. Danny Rittman, GBT s CTO, explained: